HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance

The introduction of anti-HER2 therapies to the treatment of patients with HER2-positive breast cancer has led to dramatic improvements in survival in both early and advanced settings. Despite this breakthrough, nearly all patients with metastatic HER2-positive breast cancer eventually progress on an...

Descripción completa

Detalles Bibliográficos
Autores principales: Pernas, Sonia, Tolaney, Sara M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425535/
https://www.ncbi.nlm.nih.gov/pubmed/30911337
http://dx.doi.org/10.1177/1758835919833519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425535/
https://www.ncbi.nlm.nih.gov/pubmed/30911337
http://dx.doi.org/10.1177/1758835919833519

Ejemplares similares